CHEK2 riskScore Clinical Scenario – High Risk
A 41-year-old woman without a personal history of cancer presents to her provider to better understand her risk of breast cancer.
October 1, 2020
No Comments
Myriad Oncology Blog
Welcome
We believe that when it comes to cancer, our genetic tests provide critical information for both providers and patients. Follow our blog to learn more about our solutions.
Categories
CHEK2 riskScore Clinical Scenario – Low Risk
A 41-year-old woman without a personal history of cancer presents to her provider to better understand her risk of breast cancer.
September 23, 2020
No Comments
CHEK2 riskScore Clinical Scenario – Moderate Risk
A healthy 37-year-old woman approaches her doctor because she is concerned about her risk of breast cancer.
September 17, 2020
No Comments
Cost of Myriad myRisk Testing
Cost should never be a barrier when patients need genetic testing. That’s why it’s Myriad’s promise to make testing accessible and affordable. For patients
August 10, 2020
No Comments
Variant Reclassification
Why is Variant Reclassification in Hereditary Cancer Testing Important? Variant classification is a key component of germline testing, allowing patients to have an accurate answer
July 20, 2020
No Comments
CHEK2 Carrier Modification with Polygenic Risk Score
High and moderate penetrant genes, such as BRCA1, BRCA2, PALB2, CHEK2, and ATM, account for approximately 25% of familial breast cancer risk.
July 7, 2020
No Comments
Myriad Oncology Live – Weekly Educational Webinar Series
In my new role as Senior Vice President of Medical Affairs of Myriad Oncology, I want to be completely accessible to our providers. Because of
July 1, 2020
No Comments
An Overview of riskScore
Myriad’s riskScore helps to refine a woman’s risk of breast cancer, with or without a family history of breast cancer.
June 9, 2020
No Comments
Myriad Corporate Statement
We are heartbroken over the systemic discrimination and racism that have persisted in this nation for too long. We have been quiet in reflection but
June 9, 2020
No Comments
Introducing the Inside the GENOME Podcast
Hosted by Dr. Thomas Slavin, Senior Vice President of Medical Affairs for Myriad Oncology, Inside the GENOME is a casual, educational podcast exploring the world
June 4, 2020
No Comments
